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The pancreatic stone protein (PSP) isolated from calculi (Mr 14000) and the 5 protein forms (PSP Sl-5) 
detected in pancreatic juice (Mr 1400&19000) derive from the same source differing seemingly in their car- 
bohydrate contents or/and in their polypeptidic chain lengths. This kind of protein would inhibit in vivo 
CaCO,-crystal growth in pancreatic juice. PSP and PSP Sl N-terminal sequences are identical (NH,Ile-). 
This report demonstrates that: (i) in PSP S2-5 the amino-terminal is blocked; (ii) the C-terminus is alike 
in every form; (iii) the single polypeptide chain of PSP S2-5 is converted into that of PSP Sl or PSP by 
the specific trypsin cleavage of the Arg-Ile bond. 
Pancreatic stone protein; Pancreatic juice; Specific trypsin cleavage; End group analysis; Carboxypeptidase Y digestion; 
Carboxypeptidase P digestion; (Human pancreatic alculi) 
1. INTRODUCTION 
With the isolation of the pancreatic stone pro- 
tein, PSP (Mr 14000) from calculi of patients suf- 
fering from chronic calcifying pancreatitis [l], it 
was possible to reveal by immunolocalization that 
the initial form of the protein is synthesized in pan- 
creatic acinar cells and that it follows the same 
pathway as the digestive enzymes [2]. 
Using an immobilized monoclonal antibody 
against PSP, several forms of protein (PSP Sl-5) 
with different Mr (14000-19000) were detected in 
pancreatic juice [3]. The differences in these pro- 
tein forms might result from proteolytic 
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cleavage(s) in the polypeptide chain and/or varia- 
tions in carbohydrate contents. The role of this 
protein would be to inhibit in vivo the 
CaCO3-crystal growth in pancreatic juice [4]. The 
smallest form, PSP Sl, and the protein prepared 
from calculi, PSP, display the same elec- 
trophoretic migration in the presence of SDS [5]. 
In [5] it has been shown that Ile is the N-terminal 
amino acid in both proteins and that their N- 
terminal sequences are identical (the 40 and 65 first 
amino acids are known in PSP and PSP S 1, respec- 
tively). Moreover, the same N-terminal sequence 
of the 45 first amino acids has been found in the 
protein called ‘human pancreatic thread protein’ 
by the authors [6] indicating that all these proteins 
derive from the same source. It is of great interest 
to proceed further with the structure comparison 
between PSP, PSP Sl and PSP S2-5 in order to 
understand the mechanism of formation of the 
modified forms. Here, the results on the deter- 
mination of N- and C-terminal amino acid residues 
and the sequences of two homologous cystine pep- 
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tides resulting from the pepsin hydrolysis of PSP 
Sl and PSP S2-5 are compared. Limited pro- 
teolyses on PSP S2-5 are performed. 
2. EXPERIMENTAL 
Several methods have already been described: 
purification of PSP, PSP Sl and PSP S2-5 [5]; 
dansylation and amino acid analysis [7]. The pep- 
tide chromatography was performed on thin-layer 
cellulose (cell 400 Macherey Nagel) and developed 
in the solvent system butanol/pyridine/acetic 
acid/water (60 : 40 : 12 : 48, v/v, pH 4.8) according 
to the directions in [8]. Electrophoreses on thin- 
layer cellulose were conducted with buffer 
(pyridine/acetic acid/acetone/water, 20 : 40 : 150 :
790, pH 4.4) for 3 h at 300 V. The peptides were 
located using fluorescamine (0.01070). The cystine- 
containing peptides were revealed on aliquots with 
nitroprusside reagent [9]. The automated Edman 
degradation of peptide BlOGl (5 nmol) was car- 
ried out in a gas-phase sequencer (Applied Biosys- 
terns, model 470A). The PTH-amino acids were 
analyzed by HPLC on a Waters chromatograph 
using an ODS 5 pm Beckman column. The condi- 
tions for enzymatic digestions were as follows: 
protein (1.2-1.3 pmol) in 6 ml of 5% formic acid 
was incubated with pepsin (enzyme/substrate, 
1: 10, w/w) at 37°C. After 20 h, an equal amount 
of enzyme was added and the digestion was pur- 
sued 4 h more. The peptide Al (100 nmol) in 
0.1 ml 60 mM ammonium bicarbonate buffer (pH 
8.5) was digested with TPCK-trypsin (enzyme/ 
substrate, 1:20, w/w) for 30 min at 25°C. The 
peptide Bl (200 nmol) in 0.5 ml of 60 mM am- 
monium bicarbonate (pH 7.8) was digested with S. 
aureus V8 protease (enzyme/substrate, 1: 40, w/w) 
for 18 h at 37°C. For C-terminal determination, 
70 GM native or carboxymethylated reduced pro- 
tein in 60 ~1 of 50 mM pyridine acetate buffer (pH 
5.5), 6 M in urea, were incubated with 1: 10 (w/w) 
carboxypeptidase P or Y (Boehringer Mannheim) 
for 3 h at 25°C and 20 h at 37°C respectively. The 
hydrolysates were directly investigated on an 
amino acid analyzer. 
3. RESULTS AND DISCUSSION 
3.1. N- and C-terminus determination 
Analyses were performed on the PSP S2-5 mix- 
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ture since it has been impossible up to now to 
separate these protein forms. No N-terminal 
amino acid was found in carboxymethylated 
reduced PSP S2-5 using the dansyl method or 
automated Edman degradation. In the determina- 
tion of C-terminal end of PSP, PSP Sl and PSP 
S2-5 by carboxypeptidases Y and P, the following 
results were obtained: (i) no amino acid was re- 
leased from the proteins, even in presence of 6 M 
urea; (ii) the carboxymethylated reduced proteins, 
in 6 M urea, gave negative results with carboxy- 
peptidase Y, whereas three amino acids (Lys, Asn 
and Phe) were freed with acid carboxypeptidase P 
(in the ratios of 1, 1 and 0.5 respectively) from the 
different forms of pancreatic stone protein. This 
last experiment shows that the C-terminal se- 
quences of PSP, PSP Sl and PSP S2-5 are iden- 
tical and suggests that the formation of PSP Sl 
would be the result of cleavage(s) in the N-terminal 
sequence of the native protein. 
a 
350 400 450 500 
Fractions 
Fig. 1. Gel filtration on Sephadex G-50 (superfine) of the 
peptic digestions of PSP Sl and PSP S2-5. Two or three 
connected columns were equilibrated and eluted with 
1% acetic acid at 5°C. The effluents were monitored at 
230 nm (-) and 280 nm (- - -). The cystine-positive 
fractions were revealed as indicated [9]. (a) The digest of 
PSP Sl (1.3 pmol) was applied to the column set (1.5 x 
425 cm). Flow rate, 6.6 ml/h; 2.0-ml fraction. (b) The 
digest of PSP S2-5 (1.2 pmol) was applied to the column 
set (1.5 x 500 cm). Flow rate, 5.6 ml/h; 2.0-ml fraction. 
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Table 1 
Various operations performed on fractions A and B in view of the identification of 
the cystine peptide they contain 
A 
I 
Chromatography - electrophoresis 
-+ cystine-positive spot: Al 
I 
Trypsin digest - chromatography 
-+ cystine-positive spot: AlT 
Oxidation - chromatography 
---+ AlTOl and AlT02 
B 
I 
Filtration Sephadex G-25 - chromatography 
--+ cystine-positive spot: Bl 
I 
S. aureus V8 protease digest - chromatography 
---+ cystine-positive spot: BlG 
I 
Oxidation - chromatography 
-+ BlGOl and BIG02 
Table 2 
Amino acid composition and sequences of peptides deriving from the fractions A and B (table 1) 
Amino acid Al AlTOl AlT02 Bl BlGOl BlG02 
a b a b a b a b a b a b 
CYS 
Asx 
Thr 
Ser 
Glx 
Pro 
Gly 
Ala 
Val 
Met 
Be 
Leu 
Tyr 
Phe 
His 
LYS 
Arg 
Trp 
1.5 (2) 0.8 (1) 1.0 (1) 1.5 (2) 1.2 (1) 0.9 (1) 
1.2 (1) 1.0 (1) 0.9 (1) 0.1 0.8 (1) 
0.7 (1) 0.9 (1) 1.3 (1) 1.0 (1) 
1.8 (2) 0.8 (1) 0.6 (1) 2.2 (2) 1.0 (1) 1.0 (1) 
1.0 (1) 1.0 (1) 1.0 (1) 1.0 (1) 
0.8 (1) 1.0 (1) 1.0 (1) 1.0 (1) 
1.5 (1) 1.0 (1) 0.3 1.6 (1) 0.2 1.3 (1) 
1.4 (1) 0.9 (1) 1.2 (1) 0.1 1.1 (1) 
1.0 (1) 0.8 (1) 1.0 (1) 1.0 (1) 
3.0 (3) 0.9 (1) 1.7 (2) 2.7 (3) 2.8 (3) 
1.3 (1) 0.9 (1) 2.2 (2) 1.0 (1) 1.0 (1) 
Total residues (15) (11) (4) (16) 
N-terminal residue Ile Ile Ser n.d. 
Al Ile Ser Cys Pro Glu Gly Thr Asn Ala Tyr Arg Ser Tyr Cys Tyr 
I 
BlGOl Arg Ile Ser Cys Pro Glu 
(6) 
Arg 
(10) 
Gly 
Bl Arg Ile Ser Cys Pro Glu Gly Thr Asn Ala Tyr Arg Ser Tyr Cys Tyr 
J 
Values a are data of ‘24 h hydrolysis without corrections for losses; values b refer to the sequence of the characterized 
peptide. For Al and Bl two hydrolyses were performed before and after performic acid oxidation 
197 
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3.2. Comparison of two homologous pepsin 
peptides from PSP SI and PSP S2-5 
When PSP Sl was hydrolyzed by pepsin and the 
hydrolyzate filtered on Sephadex, the elution pro- 
file displayed a peak (peak A) sharply separated 
from the rest of the diagram (fig.la). As will be 
demonstrated below, the major peptide purified 
from fractions A revealed to be the cystine pen- 
tadecapeptide representing the 15 first amino acids 
of PSP Sl [5]: 
1 
I 
15 
Ile Ser Cys Pro Glu Gly Thr Asn Ala Tyr Arg Ser Tyr Cys Tyr 
Similar operations were tentatively performed on 
the PSP S2-5 mixture with a view to obtaining a 
homologous cystine peptide with a few amino 
acids preceding Ile. This would allow the deter- 
mination of the nature of the bond cleaved in the 
formation of PSP Sl. Fig.lb shows the Sephadex 
elution pattern of the pepsin hydrolysate of PSP 
S2-5. In the diagram, peak B is comparable to peak 
A (fig.lA) and its fractions were also cystine- 
positive. The different operations carried out on 
fractions A and B are given in table 1. The 
characterizations of most of the peptides men- 
tioned in table 1 are indicated in table 2. In the case 
of Al, its amino acid composition and the fact that 
its N-terminal amino acid is an isoleucine provided 
sufficient support to conclude that it represents the 
sequence of the 15 first amino acids of PSP Sl [5]; 
since Al was a cystine-containing peptide it is ob- 
vious that an S-S bridge connected Cys 3 to Cys 14. 
Moreover these data were confirmed by the study 
of the trypsin digest of Al. The cystine peptide 
AlT had the same amino acid composition as Al 
and after oxidation two cysteic peptides were 
separated. AlTOl and AlT02 had the anticipated 
amino acid compositions. In the case of Bl, its 
amino acid composition had an extra arginine 
compared to that of Al. After digestion with 
staphylococcal protease, the cystine peptide BlG 
obtained had the same composition as Bl. After 
oxidation of BIG, two cysteic peptides BlGOl and 
BlG02 were separated. The automatic sequence 
performed on BlGOl definitely proved that the ex- 
tra Arg immediately precedes Ile (table 2). It is 
concluded that the PSP Sl form arises from 
cleavage of the Arg-Ile bond in the native protein. 
Seemingly, the same process has given rise to the 
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polypeptide chain of PSP, the protein found in 
pancreatic stones. 
3.3. Limited proteolysis of PSP S2-5 by trypsin 
and chymotrypsin 
The electrophoretic patterns (fig.2) showed that 
trypsin transformed PSP S2-5 into a major protein 
displaying a migration similar to that of PSP Sl. 
It is interesting to note that this proteolysis was 
concomitant with the protein precipitation. In con- 
trast, despite the great amount of enzyme in- 
volved, chymotrypsin did not cleave native PSP 
S2-5 efficiently. The determination of the N- 
terminal amino acid(s) in the digest confirmed the 
123466789 
Fig.2. Limited proteolyses of PSP S2-5 by trypsin and 
chymotrypsin. Comparison of the electrophoretic 
patterns of the digests with those of PSP Sl and PSP 
S2-5. 15% polyacrylamide-SDS slab gel electrophoresis 
was carried out according to [lo]. Before electrophoresis 
the protein samples were denatured, reduced and S- 
carboxymethylated. PSP S2-5 (lanes 1,9), PSP Sl (lanes 
2,8). The proteolyses of PSP S2-5 (226pM in 5 mM 
Tris-HCl buffer, pH 7.9, 40 mM in NaCl plus 20 mM in 
CaCll in the case of trypsin) were performed for 1 h at 
25°C with 0.1, 1 and 5% (w/w) TPCK-treated trypsin 
(lanes 3-5, respectively) and with 3 and 10% (w/w) 
TLCK-treated chymotrypsin (lanes 6,7). The reactions 
were arrested with 1 mM diisopropyl fluorophosphate 
for trypsin or 1 mM phenylmethylsulfonyl fluoride for 
chymotrypsin. 
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electrophoresis results. In the case of chymotryp- REFERENCES 
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sin, several poorly represented amino end groups 
were detected. In the case of trypsin, an important 
single N-terminal amino acid corresponding to Ile 
was found. 
All the present results show that the Arg-Ile 
bond in PSP S2-5 is particularly susceptible to 
trypsin hydrolysis and suggest hat the conversion 
of PSP S2-5 polypeptide chain into that of PSP Sl 
or PSP occurs in vivo by trypsin proteolysis. 
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